• Return to Headlines

Xencor Inc Shares Up 29.5% Since SmarTrend's Buy Recommendation (XNCR)

By David Diaz

SmarTrend identified an Uptrend for Xencor Inc (NASDAQ:XNCR) on May 14th, 2018 at $32.16. In approximately 1 month, Xencor Inc has returned 29.47% as of today's recent price of $41.63.

Over the past year, Xencor Inc has traded in a range of $18.55 to $43.39 and is now at $41.62, 124% above that low. The 200-day and 50-day moving averages have moved 1.24% higher and 2.26% higher over the past week, respectively.

Xencor, Inc. develops antibody and protein therapeutics to treat cancer and autoimmune inflammation. The Company markets its products to healthcare providers and facilities throughout the United States and internationally.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Xencor Inc shares.

Log in and add Xencor Inc (XNCR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights xencor inc

Ticker(s): XNCR